Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Live Broadcast to Explore a Second Line Treatment Option for HER2+ Metastatic Breast Cancer
Register to join us LIVE in Chicago for Giants of Cancer Care®
Subscribe to our eNewsletter for breaking news and curated content
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Live Broadcast to Explore a Second Line Treatment Option for HER2+ Metastatic Breast Cancer
Register to join us LIVE in Chicago for Giants of Cancer Care®
Subscribe to our eNewsletter for breaking news and curated content
Specialty
View More
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Partners
Interactive Tools
Learning Modules
Presentations
Sponsored
Partners
Subscribe
eNewsletter
Print Subscription
eNewsletter
Print Subscription
Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Live Broadcast to Explore a Second Line Treatment Option for HER2+ Metastatic Breast Cancer
Register to join us LIVE in Chicago for Giants of Cancer Care®
Subscribe to our eNewsletter for breaking news and curated content
Specialty
See All >
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
ASCO 2018 News - Episode 5
Practice Changes for Use of Immunotherapy in NSCLC
June 2, 2018
EP. 1: OncLive News Network On Location: In Chicago Friday, June 1
EP. 2: OncLive News Network On Location: In Chicago Saturday, June 2
EP. 3: OncLive News Network On Location: In Chicago Sunday, June 3
EP. 4: OncLive News Network On Location: In Chicago Monday, June 4
Now Viewing
EP. 5: Practice Changes for Use of Immunotherapy in NSCLC
EP. 6: ASCO 2018: Dr. Borghaei Highlights Immunotherapy Findings in Lung Cancer
EP. 7: ASCO 2018: Dr. Esteva Highlights CDK4/6 Inhibitors and More in Breast Cancer
EP. 8: ASCO 2018: Dr. Burris Highlights TAILORx and More in Breast Cancer
EP. 9: ASCO 2018: Dr. Lonial Highlights CAR T-Cell Therapy and More in Myeloma
EP. 10: ASCO 2018: Dr. Weber Highlights Exciting Abstracts in Melanoma
EP. 11: ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
EP. 12: ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts
EP. 13: ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies
EP. 14: ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer
EP. 15: KEYNOTE Trial Data: Pembrolizumab's Role in NSCLC
EP. 16: Actual Use of Pembrolizumab and Chemotherapy in NSCLC
EP. 17: CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC
EP. 18: IMPower150: Implications for the Treatment of NSCLC
EP. 19: Important Data in the Squamous NSCLC Population
EP. 20: Impact of Data on the Real-Life Treatment of NSCLC
EP. 21: Tumor Mutational Burden in NSCLC: Should it be Routine?
EP. 22: Optimizing Immunotherapy in the NSCLC Treatment Paradigm
EP. 23: Using Immunotherapy Beyond Progression in NSCLC
EP. 24: Practice Changes for Use of Immunotherapy in NSCLC: Q&A